Skip to main content

RTW Venture

data as at: 14/02/2020
Company website
ObjectiveTo achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical techonology companies.
Management groupRTW Investments
AIC sectorBiotechnology & Healthcare
Launch date29/10/2019
Financial year endDecember
DomicileGuernsey

Dividends

Dividends displayed in traded currency.

There have been no dividends in the last 12 months.

Dividend cover (years)Revenue reserves (m)
N/AN/A

Trading information

ISINTIDMTraded currency
GG00BKTRRM22RTWUSD

Traded volumes (number of shares)

Yesterday1 month1 year5 years
Total2,000131,94500
AverageN/A5,73700

Traded values (m)

Yesterday1 month1 year5 years
Total0.000.190.000.00
AverageN/A0.010.000.00

Data provided by Morningstar. Company documents provided by Financial Express. 

Company announcements

Company documents